ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans
University of Arkansas for Medical Sciences at ASHI 2026
Oct 26–30, 2026 Montréal, Canada ~1k attendees Website
University of Arkansas for Medical Sciences takes part in 3 sessions at ASHI 2026 in Montréal. Its work covers HLA lab practice, including who can perform preliminary virtual crossmatches and validating nanopore sequencing for clinical HLA typing. It also reports that raised epidermal growth factor and interleukin-15 may help predict antibody-mediated and cellular rejection of kidney transplants.
| Organization | ASHI 2026 Attendance |
|---|---|
University of Arkansas for Medical Sciences Little Rock, AR | |
Public health sciences university with colleges of medicine, nursing, pharmacy, public health and health professions, plus a hospital and an HLA laboratory. | Poster HLA Technologists Can Perform Preliminary Virtual Crossmatches to be Reviewed and Verified by a Director Lab quality, accreditation and operationsHLA antibodies, crossmatching and eplets Poster Nanopore Typing Validation for Clinic Use in the HLA Laboratory HLA typing, sequencing and genotypingLab quality, accreditation and operations Poster Elevations in Epidermal Growth Factor and Interleukin-15 May Help Predict Antibody-Mediated and Cellular-Mediated Kidney Allograft Rejection, Respectively Solid organ transplantationChimerism, cell-free DNA and post-transplant monitoring |
Find decision makers at University of Arkansas for Medical Sciences
Tell us what you sell and we’ll find the people at University of Arkansas for Medical Sciences most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction